Comparison of Everolimus- and Sirolimus-Eluting Stents in Patients With Long Coronary Artery Lesions
- 18 October 2011
- journal article
- research article
- Published by Elsevier BV in JACC: Cardiovascular Interventions
- Vol. 4 (10), 1096-1103
- https://doi.org/10.1016/j.jcin.2011.05.024
Abstract
No abstract availableKeywords
Funding Information
- Cardiovascular Research Foundation
- Medtronic
- Ministry of Health and Welfare (0412-CR02-0704-0001)
- Cordis
- Abbott Laboratories
- Boston Scientific Corporation
This publication has 17 references indexed in Scilit:
- Coronary StentsJournal of the American College of Cardiology, 2010
- Correlation of Intravascular Ultrasound Findings With Histopathological Analysis of Thrombus Aspirates in Patients With Very Late Drug-Eluting Stent ThrombosisCirculation, 2009
- A Comparison of Bare-Metal and Drug-Eluting Stents for Off-Label IndicationsNew England Journal of Medicine, 2008
- 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary InterventionJournal of the American College of Cardiology, 2008
- Angiographic Surrogate End Points in Drug-Eluting Stent Trials: A Systematic Evaluation Based on Individual Patient Data From 11 Randomized, Controlled TrialsYearbook of Cardiology, 2008
- Angiographic Surrogate End Points in Drug-Eluting Stent TrialsJournal of the American College of Cardiology, 2007
- Thrombosis in Coronary Drug-Eluting StentsCirculation, 2007
- Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent for Patients With Long Coronary Artery DiseaseCirculation, 2006
- Predictive Factors of Restenosis After Coronary Implantation of Sirolimus- or Paclitaxel-Eluting StentsCirculation, 2006
- Relationship of Late Loss in Lumen Diameter to Coronary Restenosis in Sirolimus-Eluting StentsCirculation, 2005